Project Grant HC080398115

This $390,000 federal Project Grant award was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant will fund a 2-year research project at Thomas Jefferson University's Sidney Kimmel Medical College to evaluate the use of contrast-enhanced ultrasound (CEUS) and subharmonic-aided pressure estimation (SHAPE) techniques for assessing uterine fibroids before and after...

This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support research to develop non-invasive magnetic resonance imaging (MRI) techniques for early diagnosis and prediction of fetal growth restriction (FGR) during pregnancy. The $295,212 award will be used by the University of South Australia to conduct a series of predictive MRI scans in a sheep...

This $350,000 Project Grant award from the U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA) under the Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement program (CFDA 93.912) will support Ste. Genevieve County Memorial Hospital (SGCMH), a rural critical access hospital in Missouri, in addressing financial, operational, and marketing challenges. The grant funding will enable...

This $1,754,922 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports an extension trial of the drug pazopanib for treating Hereditary Hemorrhagic Telangiectasia (HHT)-related bleeding. HHT Foundation International, Inc. (doing business as Cure HHT), a non-profit organization focused on finding a cure for HHT, is the awardee. The two-year extension trial builds upon prior federal grant-funded...

The U.S. Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ) awarded a $118,089 Project Grant under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) federal grant program to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The grant will support the development and testing of a clinical decision support (CDS) tool to identify pregnant individuals at high risk for postpartum hemorrhage and...

This $717,712 Project Grant from the National Science Foundation's Division of Information and Intelligent Systems, under the Computer and Information Science and Engineering program (CFDA 47.070), will support the development and evaluation of a knowledge-enhanced and interpretable radiology report generation framework using longitudinal, multimodal electronic health record data and domain knowledge. The awardee, Joan & Sanford I Weill Medical College of Cornell University, will build a...

This federal Project Grant award, totaling $429,000.00 and granted by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research to assess placental vascularization development using contrast-enhanced ultrasound (CEUS) imaging. The research aims to determine if the SHAPE (Subharmonic Aided Pressure Estimation) technique can serve as a safe, noninvasive, and real-time tool to...

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $437,461 to 3DT Holdings, LLC, a minority-owned biomedical engineering company, to develop a novel stabilization catheter for His pacing lead implant. The goal is to refine the design of a deployable suction flute-tipped lead placement sheath to improve the mapping and placement of His leads, which are used in cardiac resynchronization...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $807,225 Project Grant under the Cardiovascular Diseases Research Program (CFDA 93.837) to the Regents of the University of California, San Francisco (UCSF). The funding supports the development and translation of hyperpolarized 13C-pyruvate MRI to assess metabolic flexibility and glycolysis-glucose oxidation coupling in patients with hypertrophic cardiomyopathy (HCM). The project aims to: 1) Advance the HP 13C-pyruvate MRI...

This federal Project Grant award of $910,994 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support a multicenter clinical trial to evaluate the effectiveness of hormonal treatments for heavy menstrual bleeding in adolescents and young adults with bleeding disorders. The primary objective is to compare outcomes related to bleeding management, quality of life, and iron storage levels after 6 months of treatment...